Author/Creator: Maasoumy, B. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Maasoumy, B.

1. Commentary: detection of low level viraemia in telaprevir‐based triple therapy for hepatitis C virus – authors' reply. Issue 5 (4th February 2014)

Authors:: Maasoumy, B.; Wedemeyer, H.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 39:Issue 5(2014)
Page Start:: 544
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir. Issue 1 (10th November 2013)

Authors:: Maasoumy, B.; Cobb, B.; Bremer, B.; Luk, K.; Halfon, P.; Aslam, S.; Manns, M. P.; Cornberg, M.; Wedemeyer, H.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 39:Issue 1(2014)
Page Start:: 85
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected patients. (July 2015)

Authors:: Wiegand, S.B.; Jaroszewicz, J.; Potthoff, A.; Höner zu Siederdissen, C.; Maasoumy, B.; Deterding, K.; Manns, M.P.; Wedemeyer, H.; Cornberg, M.
Journal:: Clinical microbiology and infection
Issue:: Volume 21:Number 7(2015:Jul.)
Page Start:: 710.e1
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Editorial: retreatment of DAA‐failures—no problem at all?. Issue 11 (17th May 2018)

Authors:: Maasoumy, B.; Höner zu Siederdissen, C.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 47:Issue 11(2018)
Page Start:: 1552
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Editorial: retreatment of DAA‐failures—no problem at all?. Issue 11 (June 2018)

Authors:: Maasoumy, B.; Höner zu Siederdissen, C.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 47:Issue 11(2018)
Page Start:: 1552
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D. (June 2015)

Authors:: Maasoumy, B.; Wiegand, S.B.; Jaroszewicz, J.; Bremer, B.; Lehmann, P.; Deterding, K.; Taranta, A.; Manns, M.P.; Wedemeyer, H.; Glebe, D.; Cornberg, M.
Journal:: Clinical microbiology and infection
Issue:: Volume 21:Number 6(2015:Jun.)
Page Start:: 606.e1
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Letter: telaprevir triple therapy in chronic hepatitis C genotype 1 patients receiving haemodialysis. Issue 11 (June 2014)

Authors:: Wiegand, J.; Maasoumy, B.; Buggisch, P.; Buslau, A.; Schiefke, I.; Berg, T.; Wedemeyer, H.; Sarrazin, C.; Hinrichsen, H.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 39:Issue 11(2014)
Page Start:: 1342
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. The clinical significance of drug–drug interactions in the era of direct‐acting anti‐viral agents against chronic hepatitis C. Issue 11 (16th October 2013)

Authors:: Maasoumy, B.; Port, K.; Calle Serrano, B.; Markova, A. A.; Sollik, L.; Manns, M. P.; Cornberg, M.; Wedemeyer, H.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 38:Issue 11/12(2013)
Page Start:: 1365
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗